In short, the poster presents data generated by using the transglycosylation workflow TransGLYCIT™ to successfully modify human IgG1 to carry either G0, G1, G2, or G2S2 glycoforms with or without core fucosylation before the ADCC activities were determined using iLite® ADCC Reporter Gene Assay from Svar Life Science.
Get your copy of the poster " Fast and Efficient Evaluation of the Impact of Fc N-glycosylation on Antibody-dependent Cellular Cytotoxicity" by following the link below.